Abnormal time-zero histology is predictive of kidney transplant outcomes

被引:2
作者
Raza, Syed Sikandar [1 ]
Agarwal, Gaurav [1 ]
Anderson, Douglas [2 ]
Deierhoi, Mark [2 ]
Fatima, Huma [4 ]
Hanaway, Michael [2 ]
Locke, Jayme [2 ]
MacLennan, Paul [2 ]
Orandi, Babak [2 ]
Young, Carlton [2 ]
Mannon, Roslyn B. [5 ]
Seifert, Michael E. [1 ,3 ]
机构
[1] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL USA
[2] Univ Alabama Birmingham, Sch Med, Dept Surg, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL USA
[4] Univ Alabama Birmingham, Dept Pathol, Sch Med, Birmingham, AL 35294 USA
[5] Univ Nebraska Med Ctr, Dept Med, Omaha, NE USA
基金
美国国家卫生研究院;
关键词
allografts; biopsy; cohort studies; kidney transplantation; reperfusion; ANTIBODY-MEDIATED REJECTION; DONOR PROFILE INDEX; LONG-TERM; RENAL-TRANSPLANTATION; ALLOGRAFT SURVIVAL; PROTOCOL BIOPSIES; GRAFT OUTCOMES; UNITED-STATES; CRITERIA; RISK;
D O I
10.1111/ctr.14676
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction Time-zero biopsies can detect donor-derived lesions at the time of kidney transplantation, but their utility in predicting long-term outcomes is unclear under the updated Kidney Allocation System. Methods We conducted a single-center retrospective cohort study of 272 consecutive post-reperfusion time-zero biopsies. We tested the hypothesis that abnormal time-zero histology is a strong indicator of donor quality that increases the precision of the kidney donor profile index (KDPI) score to predict long-term outcomes. Results We detected abnormal biopsies in 42% of the cohort, which were independently associated with a 1.2-fold increased hazard for a composite of acute rejection, allograft failure, and death after adjusting for clinical characteristics including KDPI. By Kaplan-Meier analysis, the relationship between abnormal time-zero histology and the composite endpoint was only significant in the subgroup of deceased donor kidney transplants with KDPI scores >35. Abnormal time-zero histology, particularly vascular intimal fibrosis and arteriolar hyalinosis scores, was independently associated with lower 12-month estimated GFR. Conclusion In conclusion, abnormal time-zero histology is relatively common and identifies a group of kidney recipients at increased risk for worse long-term outcomes. Further studies are needed to determine the optimal patient population in which to deploy time-zero biopsies as an additional surveillance tool.
引用
收藏
页数:10
相关论文
共 40 条
  • [1] Donor biopsy and kidney transplant outcomes: An analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database
    Bajwa, Meera
    Cho, Yong W.
    Pham, Phuong-Thu
    Shah, Tariq
    Danovitch, Gabriel
    Wilkinson, Alan
    Bunnapradist, Suphamai
    [J]. TRANSPLANTATION, 2007, 84 (11) : 1399 - 1405
  • [2] Fibrous intimal thickening at implantation as a risk factor for the outcome of cadaveric renal allografts
    Bosmans, JL
    Woestenburg, A
    Ysebaert, DK
    Chapelle, T
    Helbert, MJ
    Corthouts, R
    Jürgens, A
    Van Daele, A
    Van Marck, EA
    De Broe, ME
    Verpooten, GA
    [J]. TRANSPLANTATION, 2000, 69 (11) : 2388 - 2394
  • [3] Histopathologic Findings on Implantation Renal Allograft Biopsies Correlate With Kidney Donor Profile Index and 30-Day Serum Creatinine
    Chen, L. -X.
    Francalacci, L. C.
    Bang, H.
    De Mattos, A.
    Perez, R. V.
    Jen, K. -Y.
    [J]. TRANSPLANTATION PROCEEDINGS, 2019, 51 (03) : 639 - 646
  • [4] The Prognostic Utility of Deceased Donor Implantation Biopsy in Determining Function and Graft Survival After Kidney Transplantation
    Cockfield, Sandra M.
    Moore, Ronald B.
    Todd, Gerald
    Solez, Kim
    Gourishankar, Sita
    [J]. TRANSPLANTATION, 2010, 89 (05) : 559 - 566
  • [5] Reasons for non-use of recovered kidneys: The effect of donor glomerulosclerosis and creatinine clearance on graft survival
    Edwards, EB
    Posner, MP
    Maluf, DG
    Kauffman, HM
    [J]. TRANSPLANTATION, 2004, 77 (09) : 1411 - 1415
  • [6] The presence of glomerular sclerosis at time zero has a significant impact on function after cadaveric renal transplantation
    Escofet, X
    Osman, H
    Griffiths, DFR
    Woydag, S
    Jurewicz, WA
    [J]. TRANSPLANTATION, 2003, 75 (03) : 344 - 346
  • [7] Kidney Transplants With Progressing Chronic Diseases Express High Levels of Acute Kidney Injury Transcripts
    Famulski, K. S.
    Reeve, J.
    de Freitas, D. G.
    Kreepala, C.
    Chang, J.
    Halloran, P. F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (03) : 634 - 644
  • [8] The Kidney Donor Profile Index (KDPI) of Marginal Donors Allocated by Standardized Pretransplant Donor Biopsy Assessment: Distribution and Association With Graft Outcomes
    Gandolfini, I.
    Buzio, C.
    Zanelli, P.
    Palmisano, A.
    Cremaschi, E.
    Vaglio, A.
    Piotti, G.
    Melfa, L.
    La Manna, G.
    Feliciangeli, G.
    Cappuccilli, M.
    Scolari, M. P.
    Capelli, I.
    Panicali, L.
    Baraldi, O.
    Stefoni, S.
    Buscaroli, A.
    Ridolfi, L.
    D'Errico, A.
    Cappelli, G.
    Bonucchi, D.
    Rubbiani, E.
    Albertazzi, A.
    Mehrotra, A.
    Cravedi, P.
    Maggiore, U.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (11) : 2515 - 2525
  • [9] The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
    Haas, M.
    Loupy, A.
    Lefaucheur, C.
    Roufosse, C.
    Glotz, D.
    Seron, D.
    Nankivell, B. J.
    Halloran, P. F.
    Colvin, R. B.
    Akalin, Enver
    Alachkar, N.
    Bagnasco, S.
    Bouatou, Y.
    Becker, J. U.
    Cornell, L. D.
    van Huyen, J. P. Duong
    Gibson, I. W.
    Kraus, Edward S.
    Mannon, R. B.
    Naesens, M.
    Nickeleit, V.
    Nickerson, P.
    Segev, D. L.
    Singh, H. K.
    Stegall, M.
    Randhawa, P.
    Racusen, L.
    Solez, K.
    Mengel, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (02) : 293 - 307
  • [10] Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
    Haas, M.
    Sis, B.
    Racusen, L. C.
    Solez, K.
    Glotz, D.
    Colvin, R. B.
    Castro, M. C. R.
    David, D. S. R.
    David-Neto, E.
    Bagnasco, S. M.
    Cendales, L. C.
    Cornell, L. D.
    Demetris, A. J.
    Drachenberg, C. B.
    Farver, C. F.
    Farris, A. B., III
    Gibson, I. W.
    Kraus, E.
    Liapis, H.
    Loupy, A.
    Nickeleit, V.
    Randhawa, P.
    Rodriguez, E. R.
    Rush, D.
    Smith, R. N.
    Tan, C. D.
    Wallace, W. D.
    Mengel, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (02) : 272 - 283